Audiological Monitoring of Patients Receiving Ototoxic Drugs Over 200 medications commonly prescribed for the treatment of cancers and some infections can cause inner ear damage, or ototoxicity (ASHA, 2004). Ototoxicity can result in auditory and/or vestibular dysfunction, and the effects can be temporary, but are often permanent. Symptoms of ototoxicity include tinnitus, dizziness, and difficulty understanding ... Article
Article  |   September 01, 2005
Audiological Monitoring of Patients Receiving Ototoxic Drugs
Dawn Konrad-Martin, Jane S. Gordon, Kelly M. Reavis, Debra J. Wilmington, Wendy J. Helt, and Stephen A. Fausti
Author Affiliations & Notes
  • Dawn Konrad-Martin
    Veterans Affairs Rehabilitation Research and Development Service, National Center for Rehabilitative Auditory Research, VA Medical Center, Portland, OR
    Department of Otolaryngology, Oregon Health & Science University, Portland, OR
  • Jane S. Gordon
    Veterans Affairs Rehabilitation Research and Development Service, National Center for Rehabilitative Auditory Research, VA Medical Center, Portland, OR
  • Kelly M. Reavis
    Veterans Affairs Rehabilitation Research and Development Service, National Center for Rehabilitative Auditory Research, VA Medical Center, Portland, OR
  • Debra J. Wilmington
    Veterans Affairs Rehabilitation Research and Development Service, National Center for Rehabilitative Auditory Research, VA Medical Center, Portland, OR
  • Wendy J. Helt
    Veterans Affairs Rehabilitation Research and Development Service, National Center for Rehabilitative Auditory Research, VA Medical Center, Portland, OR
  • Stephen A. Fausti
    Veterans Affairs Rehabilitation Research and Development Service, National Center for Rehabilitative Auditory Research, VA Medical Center, Portland, OR
    Department of Otolaryngology, Oregon Health & Science University, Portland, OR
  • © 2005 American Speech-Language-Hearing Association
Article Information
Hearing Disorders / Articles
Article   |   September 01, 2005
Audiological Monitoring of Patients Receiving Ototoxic Drugs
SIG 6 Perspectives on Hearing and Hearing Disorders: Research and Diagnostics, September 2005, Vol. 9, 17-22. doi:10.1044/hhd9.1.17
SIG 6 Perspectives on Hearing and Hearing Disorders: Research and Diagnostics, September 2005, Vol. 9, 17-22. doi:10.1044/hhd9.1.17
Acknowledgments
This research was supported by the Department of Veterans Affairs Rehabilitation Research and Development Service (Grants C3213R and E3239V).
Become a SIG Affiliate
Join a SIG
Pay Per View
Entire SIG 6 Perspectives on Hearing and Hearing Disorders: Research and Diagnostics content & archive
24-hour access
This Issue
24-hour access
This Article
24-hour access
We've Changed Our Publication Model...
The 19 individual SIG Perspectives publications have been relaunched as the new, all-in-one Perspectives of the ASHA Special Interest Groups.
Learn more >